The drug received FDA approval in October 2019. Alkermes received $150m in milestone payment from Biogen in November 2019, following the FDA's approval of the drug. VUMERITY is available as delayed-release oral capsules with a starting dose of 231mg to be administered twice daily.

Is Vumerity better than Tecfidera?

Vumerity (diroximel fumarate) is easier on the gastrointestinal tract than Tecfidera (dimethyl fumarate), and this translates into better quality of life for patients with relapsing-remitting multiple sclerosis (RRMS), a new analysis of EVOLVE-MS-2 trial data has found.

Is Vumerity generic Tecfidera?

There is currently no generic form of Vumerity. A generic drug is an exact copy of the active drug in a brand-name medication. Brand-name medications usually cost more than generics. Tecfidera is a brand-name drug that contains the active drug dimethyl fumarate.